Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Klutmann

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
MMW Fortschritte Der Medizin|July 27, 2000
[Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP]S Klutmann, K H Bohuslavizki
Der Urologe. Ausg. A|March 8, 2014
[Alpha emitter radium-223 dichloride: new therapy in castration-resistant prostate cancer with symptomatic bone metastases]H Heinzer, F König, S Klutmann
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 17, 2012
[Intrapancreatic accessory spleen - an important differential diagnosis of primary pancreatic tail neoplasia]H Ittrich, S Klutmann, G Adam
Nuklearmedizin. Nuclear Medicine|July 10, 2003
[Somatostatin receptor scintigraphy in a patient with metastatic hemangiopericytoma]V Müller, S Klutmann, M Clausen
Journal of Nuclear Medicine Technology|October 8, 1999
Pregnancy testing before high-dose radioiodine treatment: a case reportK H Bohuslavizki, S Kröger, S Klutmann, et al.
Nuclear Medicine Communications|December 5, 2002
Experience with 123I-iomazenil SPECT in acute cerebral infarctionV Müller, D Saur, S Klutmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled studyK H Bohuslavizki, S Klutmann, W Brenner, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 2001
[Prevalence of iodine- and thyroglobulin-negative findings in differentiated thyroid cancer.A retrospective analysis of patients treated from 1951 to 1998 in university hospital]S Klutmann, L Jenicke, M Geiss-Tönshoff, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 1999
Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal modelK H Bohuslavizki, S Klutmann, L Jenicke, et al.
Journal of Nuclear Medicine Technology|May 14, 1999
Quantitative salivary gland scintigraphyS Klutmann, K H Bohuslavizki, S Kröger, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
MMW Fortschritte Der Medizin|July 27, 2000
[Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP]S Klutmann, K H Bohuslavizki
Der Urologe. Ausg. A|March 8, 2014
[Alpha emitter radium-223 dichloride: new therapy in castration-resistant prostate cancer with symptomatic bone metastases]H Heinzer, F König, S Klutmann
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|November 17, 2012
[Intrapancreatic accessory spleen - an important differential diagnosis of primary pancreatic tail neoplasia]H Ittrich, S Klutmann, G Adam
Nuklearmedizin. Nuclear Medicine|July 10, 2003
[Somatostatin receptor scintigraphy in a patient with metastatic hemangiopericytoma]V Müller, S Klutmann, M Clausen
Journal of Nuclear Medicine Technology|October 8, 1999
Pregnancy testing before high-dose radioiodine treatment: a case reportK H Bohuslavizki, S Kröger, S Klutmann, et al.
Nuclear Medicine Communications|December 5, 2002
Experience with 123I-iomazenil SPECT in acute cerebral infarctionV Müller, D Saur, S Klutmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled studyK H Bohuslavizki, S Klutmann, W Brenner, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 2001
[Prevalence of iodine- and thyroglobulin-negative findings in differentiated thyroid cancer.A retrospective analysis of patients treated from 1951 to 1998 in university hospital]S Klutmann, L Jenicke, M Geiss-Tönshoff, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 1999
Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal modelK H Bohuslavizki, S Klutmann, L Jenicke, et al.
Journal of Nuclear Medicine Technology|May 14, 1999
Quantitative salivary gland scintigraphyS Klutmann, K H Bohuslavizki, S Kröger, et al.
Pageof 3